. A?, amyloid-? peptide; AD, Alzheimer's disease; ANS, 8- anilino-1-naphthalenesulfonic acid; CD, circular dichroism

?. References-johnson, S. M. Connelly, S. Fearns, C. Powers, E. T. et al., The transthyretin amyloidoses: From delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug Transthyretin and the Transthyretin Amyloidoses Development of Therapeutic Strategies for the Transthyretin Amyloidoses Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture, Protein Misfolding, Aggregation, and Conformational Diseases Amyloid Fibrils and Prefibrillar Aggregates (Otzen, D. E., Ed.) pp 373?394 Prefibrillar transthyretin oligomers and cold stored native tetrameric transthyretin are cytotoxic in cell culture, pp.185-203, 2004.

M. M. Sousa, I. Cardoso, R. Fernandes, A. Guimaraes, M. J. Saraiva et al., Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: Evidence for toxicity of nonfibrillar aggregates Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity The biological and chemical basis for tissue-selective amyloid disease The V122I cardiomyopathy variant of transthyretin increases the velocity of ratelimiting tetramer dissociation, resulting in accelerated amyloidosis Prevention of transthyretin amyloid disease by changing protein misfolding energetics Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro (1996) The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants Transthyretin sequesters amyloid ? protein and prevents amyloid formation Characterization of the interaction of ?-amyloid with transthyretin monomers and tetramers, Proc. Natl. Acad. Sci. U.S.A. 99 (Suppl. 4), 16427?16432. (9) Sekijima, 713?716. (12) Colon, 8654?8660. (13), pp.4381-4392, 1992.

M. Wright, P. E. Kelly, J. W. Buxbaum, J. N. Liu, L. et al., Kinetics of inhibition of ?amyloid aggregation by transthyretin Expression of human ?-amyloid peptide in transgenic Caenorhabditis elegans Accelerated A? deposition in APPswe/PS1?E9 mice with hemizygous deletions of TTR (transthyretin) Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of A? toxicity Identification of ?-amyloid-binding sites on transthyretin Neuronal production of transthyretin in human and murine Alzheimer's disease: Is it protective? Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro, 9368?9372. (21), pp.7006-7010, 1995.

J. W. Kelly, J. W. Kelly, W. Colon, Z. Lai, H. A. Lashuel et al., Alternative conformations of amyloidogenic proteins govern their behavior Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid Protein subunit interactions and structural integrity of amyloidogenic transthyretins: Evidence from electrospray mass spectrometry Arrangement of subunits and ordering of ?strands in an amyloid sheet Localized structural fluctuations promote amyloidogenic conformations in transthyretin Partitioning conformational intermediates between competing refolding and aggregation pathways: Insights into transthyretin amyloid disease Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme Detection of two partially structured species in the folding process of the amyloidogenic protein ?2-microglobulin An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured Novel Zn 2+ binding sites in human transthyretin: Implications for amyloidogenesis and retinol-binding protein recognition Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: The relationship between stability and amyloidosis Transthyretin aggregation under partially denaturing conditions is a downhill polymerization Support for the multigenic hypothesis of amyloidosis: The binding stoichiometry of retinolbinding protein, vitamin A, and thyroid hormone influences transthyretin amyloidogenicity in vitro D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: A prescription for central nervous system amyloidosis, 977?988. (31) 379?391. (34) 11442?11452. (35) 6969?6984. (37), pp.161-181, 1988.

C. Allocatelli, S. E. Jackson, A. R. Fersht, R. H. Pires, A. Karsai et al., Folding of chymotrypsin inhibitor 2. 1. Evidence for a two-state transition Biochemistry Article dx.doi.org/10 Distinct annular oligomers captured along the assembly and disassembly pathways of transthyretin amyloid protofibrils Molecular mechanism of thioflavin-T binding to amyloid fibrils Use of the phase diagram method to analyze the protein unfoldingrefolding reactions: Fishing out the " invisible " intermediates Conformational constraints for amyloid fibrillation: The importance of being unfolded How to study proteins by circular dichroism Transient folding intermediates characterized by protein engineering, 485?494. (46) Rapid folding with and without populated intermediates in the homologous four-helix proteins Im7 and Im9. J, pp.4381-4392, 1021.

F. Bemporad, C. Capanni, M. Calamai, M. L. Tutino, M. Stefani et al., From snapshot to movie: ? analysis of protein folding transition states taken one step further Is an intermediate state populated on the folding pathway of ubiquitin? Kinetic evidence for an on-pathway intermediate in the folding of cytochrome c The plastic energy landscape of protein folding: A triangular folding mechanism with an equilibrium intermediate for a small protein domain Demonstration of a low-energy on-pathway intermediate in a fast-folding protein by kinetics, protein engineering, and simulation Exploring the cytochrome c folding mechanism: Cytochrome c552 from Thermus thermophilus folds through an on-pathway intermediate Probing solvent accessibility of transthyretin amyloid by solution NMR spectroscopy Identification of a subunit interface in transthyretin amyloid fibrils: Evidence for self-assembly from oligomeric building blocks Anatomy of an amyloidogenic intermediate: Conversion of ?-sheet to ?-sheet structure in transthyretin at acidic pH Transthyretin and the brain re-visited: Is neuronal synthesis of transthyretin protective in Alzheimer's disease? Transthyretin protects against A-? peptide toxicity by proteolytic cleavage of the peptide: A mechanism sensitive to the Kunitz protease inhibitor, ) Studying the folding process of the acylphosphatase from Sulfolobus solfataricus. A comparative analysis with other proteins from the same superfamily Proc. Natl. Acad. Sci. U.S.A. 96, 477? 480. (54) Proc. Natl. Acad. Sci. U.S.A. 101, 6450?6455. (56), pp.9116-9126, 1999.